Letters Coronary artery disease: screen or treat?

Authors’ reply to Perry

BMJ 2016; 353 doi: http://dx.doi.org/10.1136/bmj.i2031 (Published 12 April 2016) Cite this as: BMJ 2016;353:i2031
  1. Darrel P Francis, professor1,
  2. Graham D Cole, specialty registrar1
  1. 1International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, London W2 1LA, UK
  1. d.francis{at}imperial.ac.uk

We thank Perry for raising the interesting difference between research trials where both patients and staff are blinded to whether the tablet is really a statin and everyday practice where patients and doctors know whether a statin is being taken.1 2 In the blinded trials, there …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe